ÂØ¿¨Ä¹£¨Lecanemab£©ÑéÖ¤ÐÔIIIÆÚClarity-ADÑо¿µ½´ïÁËÖ÷ÒªÖյ㠣¬ÔÚ1795ÃûÔçÆÚ°¢¶û´Äº£Ä¬²¡ÊÜÊÔÕߵĴóÐÍÈ«ÇòÁÙ´²Ñо¿ÖÐÏÔʾÔÚ¼õÉÙÁÙ´²Ë¥ÍË·½Ãæ¾ßÓи߶ÈÏÔÖøͳ¼ÆѧÒâÒå

¡¤ Ñо¿ËùÓдÎÒªÖÕµã¾ùµ½´ï £¬½á¹ûÏÔʾ³ö¸ßÏÔÖøͳ¼ÆѧÒâÒå

¡¤ µí·ÛÑùÂÑ°×Ïà¹ØµÄÓ°ÏñѧÒì³££¨ARIA£©µÄ·¢ÉúÂÊÔÚÔ¤ÆÚÖ®ÄÚ

¡¤ À´Àû¹ú¼Êw66¹Ù·½ÍøÕ¾µÄÄ¿±êÊÇÔÚÃÀ¹úÉêÇëͨÀýÅú×¼ £¬²¢ÔÚ2022ÄêÀ´Àû¹ú¼Êw66¹Ù·½ÍøÕ¾²ÆÕþÄê¶È½áÊøÇ°£¨2023Äê3ÔÂ31ÈÕ£©ÔÚÈÕ±¾ºÍÅ·ÖÞÌá½»ÉÏÊÐÐí¿ÉÉêÇë¡£

 

¶«¾©ºÍ½£ÇÅ £¬À´Àû¹ú¼Êw66¹Ù·½ÍøÕ¾Öêʽ»áÉç(×ܲ¿:¶«¾© £¬CEO: ÄÚÌÙÇç·ò £¬¡°À´Àû¹ú¼Êw66¹Ù·½ÍøÕ¾¡±)ºÍ²³½¡(ÄÉ˹´ï¿Ë:BIIB £¬¹«Ë¾×ܲ¿:ÂíÈøÖîÈûÖݽ£ÇÅ £¬CEO: Michel Vounatsos £¬¡°²³½¡¡±)Ðû²¼ £¬À´Àû¹ú¼Êw66¹Ù·½ÍøÕ¾ÂØ¿¨Ä¹£¨¿ª·¢´úÂë:BAN2401£©µÄ´óÐÍÈ«ÇòÈýÆÚÑéÖ¤Clarity ADÈ¡µÃÁËÑôÐÔ¶¥Ïß½á¹û¡£ÊÔÑéÒ©ÎïÂØ¿¨Ä¹ÊÇÖÎÁÆÄÔÄÚÈ·ÈÏ´æÔÚµí·ÛÑùÂѰײ¡ÀíµÄ°¢¶û´Äº£Ä¬²¡£¨AD£©ËùÖÂÇá¶ÈÈÏÖªÕÏ°­£¨MCI£©ºÍÇá¶ÈAD(ͳ³ÆΪÔçÆÚAD)µÄ¿¹µí·ÛÑùÂÑ°× (A¦Â) Ô­ÏËά¿¹Ìå¡£ÂØ¿¨Ä¹µ½´ïÖ÷ÒªÖÕµã(CDR-SB£ºÁÙ´²³Õ´ôÆÀ·Ö×ܺÍÁ¿±í)ºÍËùÓÐÒªº¦´ÎÒªÖյ㠣¬½á¹û¾ßÓи߶Èͳ¼ÆѧÒâÒå¡£À´Àû¹ú¼Êw66¹Ù·½ÍøÕ¾½«ÓëÃÀ¹ú¡¢ÈÕ±¾ºÍÅ·ÖÞ¼à¹Ü²¿ÃÅÌÖÂÛÕâЩÊý¾Ý £¬À´Àû¹ú¼Êw66¹Ù·½ÍøÕ¾µÄÄ¿±êÊÇÔÚÃÀ¹úÉêÇëͨÀýÅú×¼ £¬²¢ÔÚ2022ÄêÀ´Àû¹ú¼Êw66¹Ù·½ÍøÕ¾²ÆÕþÄê¶È½áÊøÇ°£¨2023Äê3ÔÂ31ÈÕ£©ÔÚÈÕ±¾ºÍÅ·ÖÞÌá½»ÉÏÊÐÐí¿ÉÉêÇë¡£´ËÍâ £¬À´Àû¹ú¼Êw66¹Ù·½ÍøÕ¾½«ÓÚ2022Äê11ÔÂ29ÈÕÔÚ°¢¶û´Äº£Ä¬²¡ÁÙ´²Ñо¿´ó»á(CTAD)չʾClarity ADµÄÑо¿½á¹û £¬²¢ÔÚͬÐÐÆÀÉóµÄҽѧÔÓÖ¾ÉÏ·¢±í¡£

 

*CDR-SBÊÇÒ»ÖÖÊý×ÖÁ¿±í £¬ÓÃÓÚÁ¿»¯³Õ´ôµÄÖÖÖÖÑÏÖØˮƽ¡£»ùÓÚ¶ÔAD»¼Õß¼°Æä¼ÒÍ¥/»¤ÀíÈËÔ±½øÐзÃ̸ £¬¾ß×ÊÖʵÄÒ½ÁÆרҵÈËÔ±¶ÔÈÏÖªºÍ¹¦Ð§ÌåÏÖÁù¸öÁìÓò½øÐÐÆÀ¹À£º¼ÇÒä¡¢¶¨Ïò¡¢ÅжϺͽâ¾öÎÊÌâµÄÄÜÁ¦ £¬ÉçÇøÊÂÎñ¡¢¼ÒÎñÓëÒµÓàϲºÃ¡¢¸öÈË×ÔÀíÄÜÁ¦¡£Áù¸öÁìÓòµÄ×Ü·ÖΪCDR-SBµÄ·ÖÊý £¬CDR-SBÒ²±»ÓÃ×÷ÆÀ¹ÀÕë¶ÔADÔçÆڽ׶εÄÖÎÁÆÒ©ÎïÓÐЧÐÔµÄÊʺÏÁ¿±í¡£

 

ÂØ¿¨Ä¹ÖÎÁƵ½´ïÊÔÑéÖ÷ÒªÖյ㠣¬½ÓÊÜÖÎÁÆ18¸öÔºó £¬ÆÀ¹ÀÈÏÖªºÍ¹¦Ð§ÄÜÁ¦µÄÆÀ·ÖÁ¿±íCDR-SBµÄÁÙ´²Ë¥ÍË·ù¶ÈÓëο½å¼Á×éÏà±È¼õ»º27%¡£ÔÚÒâÏòÖÎÁÆȺÌåÖдú±í×ÅÆÀ·ÖÖµ²îÒìΪ-0.45£¨p=0.00005£©¡£ÔÚ½ÓÊÜÖÎÁÆ6¸öÔÂʱ £¬ÂØ¿¨Ä¹×é¾ÍÓëο½å¼Á×é·ºÆðͳ¼ÆÏÔÖøÇø±ð¡£ËùÓÐÒªº¦ÐÔ´ÎÒªÖÕµãÒ²¾ßÓÐͳ¼ÆÏÔÖø¸ÄÉÆ£¨p<0.01£©¡£´Ó6¸öÔ¿ªÊ¼ £¬ÔÚËùÓÐʱ¼äµãÉÏ £¬ÖÎÁÆÏÔʾ³ö¸ß¶Èͳ¼ÆѧÒâÒ壻Óëο½å¼ÁÏà±È £¬×Ô»ùÏßCDR-SBµÄ±ä»¯(ËùÓÐpÖµ¾ùСÓÚ0.01)¡£Óëο½å¼Á±ÈÁ¦ £¬ËùÓÐÒªº¦´ÎÒªÖÕµãÒ²µ½´ïÁ˸߶Èͳ¼ÆѧÒâÒåµÄ½á¹û(p<0.01)¡£Òªº¦´ÎÒªÖÕµãÊÇÒÔÏÂÖ¸±ê18¸öÔÂʱÓëο½å¼ÁÖÎÁÆÏà±ÈµÄ»ùÏ߱仯£ºPET¼ì²âÕÉÁ¿´óÄÔÖеĵí·ÛÑùÂÑ°×ˮƽ £¬ADÆÀ¹ÀÁ¿±í-ÈÏÖªÑDZí14 (ADAS-cog14)¡¢AD×ÛºÏÆÀ·Ö(ADCOMS)ºÍ°¢¶û×Ⱥ£Ä¬²¡Ð­×÷Ñо¿×é MCI ÈÕ³£»î¶¯±í(ADCS MCI-ADL)¡£

 

Ó뿹µí·ÛÑùÂѰ׿¹ÌåÏà¹ØµÄ²»Á¼·´Ó³ £¬µí·ÛÑùÂÑ°×Ïà¹ØÓ°ÏñѧÒì³£-Ë®Ö×/Éø³ö(ARIA-E)µÄ·¢ÉúÂÊ £¬ÔÚÂØ¿¨Ä¹×éΪ12.5% £¬ÔÚο½å¼Á×éΪ1.7%£»Ö¢×´ÐÔARIA-E·¢ÉúÂÊÂØ¿¨Ä¹×éµÄΪ2.8% £¬Î¿½å¼Á×éΪ0.0%¡£ARIA-H (ARIAÄÔ΢³öѪ £¬ÄÔ´ó³öѪ £¬ºÍÄÔƤÖÊÍâòÌú³Á»ý)ÂØ¿¨Ä¹×éΪ17.0% £¬Î¿½å¼Á×éΪ8.7%£»Ö¢×´ÐÔARIA-HÔÚÂØ¿¨Ä¹×éΪ0.7% £¬ÔÚο½å¼Á×éΪ0.2%¡£ÖÎÁÆ×éºÍο½å¼Á×éÔÚÁæØêµÄARIA-H£¨¼´Î´·¢ÉúARIA-EµÄ»¼Õß·ºÆðARIA-H£©µÄ·¢Éú·½ÃæÀàËÆ £¬·Ö±ðΪÖÎÁÆ×飨8.8%£©ºÍο½å¼Á×飨7.6%£©¡£ARIA (ARIA-EºÍ/»òARIA-H)ÔÚÂØ¿¨Ä¹ÖеÄ×Ü·¢²¡ÂÊΪ21.3% £¬Î¿½å¼Á×éΪ9.3%¡£×ÜÌå¶øÑÔ £¬ÂØ¿¨Ä¹µÄARIA·¢²¡ÂÊÔÚÔ¤ÆÚ·¶Î§ÄÚ¡£

 

Clarity ADÊÇÒ»Ïîο½å¼Á¶ÔÕÕ £¬Õë¶ÔÔçÆÚ AD »¼ÕßµÄÈ«Çò¶àÖÐÐÄRCTÑо¿ £¬ÄÉÈë1795λ»¼Õß¡£ÊÜÊÔÕßÒÔ1:1µÄ±ÈÀý·ÖÅ䵽ο½å¼Á×é»òÖÎÁÆ×é £¬ÖÎÁÆ×éÿÁ½ÖܸøÓè10 mg/kg µÄÂØ¿¨Ä¹¡£Î¿½å¼Á×éºÍÂØ¿¨Ä¹×éµÄ»ùÏßÌØÕ÷ÏàËÆÇÒÆ¥Åä¡£Èë×é³ß¶ÈÔÊÐí»¼Õß¾ßÓкϲ¢Ö¢¼°ºÏ²¢ÓÃÒ© £¬°üÂÞ£º¸ßѪѹ¡¢ÌÇÄò²¡¡¢ÐÄÔಡ¡¢·ÊÅÖÖ¢¡¢Éö²¡ºÍ¿¹Äý¼ÁµÈ¡£À´Àû¹ú¼Êw66¹Ù·½ÍøÕ¾µÄClarity ADÑо¿ÕÐļ·½°¸È·±£Á˸ü¶à²îÒìÖÖ×åºÍÈËÖÖµÄÊÜÊÔÕß¼ÓÈë £¬ÃÀ¹ú×ÜÈë×éµÄ25%ΪÎ÷°àÑÀÒáºÍ·ÇÒáÃÀ¹úÈË¡£»ùÓڸðüÈÝÐÔµÄÕÐļ·½°¸ £¬Clarity ADµÄÈë×éÈËȺÓëÃÀ¹úÒ½ÁƱ£ÏÕµÄÈËȺÌصãÏ൱¡£

 

À´Àû¹ú¼Êw66¹Ù·½ÍøÕ¾CEO ÄÚÌÙÇç·òÌåÏÖ £¬¡°×Ô90Äê´úÄ© £¬À´Àû¹ú¼Êw66¹Ù·½ÍøÕ¾ÔÚÃÀ¹úºÍÈÕ±¾ÍƳö°²ÀíÉê £¬²¢ÔÚÈ«Çò100 ¶à¸ö¹ú¼ÒÉÏÊÐÒÔÀ´ £¬À´Àû¹ú¼Êw66¹Ù·½ÍøÕ¾Ò»Ö±ÔÚΪ³Õ´ô»¼ÕßÌṩÖÎÁÆ·½°¸ £¬²¢Í¨¹ý¼²²¡½ÌÓýºÍÉçÇø»î¶¯ÎªÓ뻼Õß¼°¼ÒÊô½¨Á¢¹²Ê¶¡£×Ô°²ÀíÉêÍƳöµÄ25Äêºó £¬ÂØ¿¨Ä¹µÄÑôÐÔ½á¹ûÊÇÀ´Àû¹ú¼Êw66¹Ù·½ÍøÕ¾ÂÄÐÐÂú×ã°¢¶û´Äº£Ä¬²¡ÉçÇøÆÚÍûµÄʹÃüµÄÒ»¸öÖØÒªÀï³Ì±®¡£°¢¶û´Äº£Ä¬²¡²»½ö¸ø»¼Õß¼°Æä¼ÒÊô´øÀ´Á˾޴óÌôÕ½ £¬¶øÇÒ»¹¶ÔÉç»á·¢ÉúÁ˸ºÃæÓ°Ïì £¬°üÂÞÉú²úÁ¦Ï½µ¡¢Éç»á³É±¾Ôö¼ÓºÍÓë¼²²¡Ïà¹ØµÄ½¹ÂÇ·¢Éú¡£ÎÒÃÇÏàÐÅ £¬×ÊÖú¼õÇáÕâЩ¸ºµ£½«¶ÔÕû¸öÉç»á·¢Éú»ý¼«Ó°Ïì¡£´ËÍâ £¬Clarity ADÑо¿½á¹û½øÒ»²½Ö¤ÊµÁ˵í·ÛÑùÂÑ°×¼Ù˵ £¬´óÄÔÖÐA¦ÂµÄÒì³£»ýÀÛÊÇ°¢¶û´Äº£Ä¬²¡µÄÖ÷ÒªÔ­ÒòÖ®Ò» £¬°ÐÏòÔ­ÏËά¿É×÷ΪÖÎÁÆÊֶΡ£À´Àû¹ú¼Êw66¹Ù·½ÍøÕ¾ÏàÐÅÕâЩ·¢ÏÖ½«Îª°¢¶û´Äº£Ä¬²¡µÄÕï¶ÏºÍÖÎÁÆ¿ª±ÙеÄÊÓÒ° £¬²¢½øÒ»²½¼¤·¢ÐÂÖÎÁÆ·½°¸µÄ´´Ð¡£Èç¹ûûÓÐÑо¿¼ÓÈëÕß¡¢ËûÃǵļÒÈ˺ͻ¤ÀíÈËÔ±ÒÔ¼°ÊÀ½ç¸÷µØµÄÁÙ´²Ñо¿ÈËÔ±µÄ·îÏ×¾«Éñ £¬Clarity ADÁÙ´²ÊÔÑéÊDz»ÐÐÄÜÀֳɵÄ¡£ÎÒÃÇллËùÓмÓÈëÕâÏîÑо¿µÄÈ˵ÄÖ§¸¶Óë·îÏס£¡±

 

²³½¡CEO Michel VounatsosÌåÏÖ £¬¡°½ñÌìµÄͨ¸æΪAD»¼Õß¼°Æä¼ÒÊô´øÀ´ÐµÄÏ£Íû £¬Èç¹ûÂØ¿¨Ä¹»ñµÃÅú×¼ £¬Ëü¿ÉÄÜ»á¼õ»º°¢¶û´Äº£Ä¬²¡µÄ½øÕ¹ £¬²¢¶ÔÈÏÖª¹¦Ð§ºÍÉú»îÄÜÁ¦´øÀ´¾ßÓÐÁÙ´²ÒâÒåµÄ»ñÒæ¡£¡± ¡°ÖØÒªµÄÊÇ £¬¸ÃÑо¿±íÃ÷ £¬´óÄÔÖоۼ¯µÄ¦Âµí·ÛÑùÂÑ°×µÄÇå³ýÓëÔçÆÚ»¼ÕßµÄÁÙ´²Ö¢×´ÑÓ»ºÏà¹Ø¡£ÎÒÃÇҪлл¼ÓÈëÕâÏ´´ÐÔÑо¿µÄËùÓл¼Õß £¬²¢Ð»Ð»ÁÙ´²Ñо¿ÈËԱΪÔö¼Ó»¼ÕßÈë×éµÄ²»Ð¸Å¬Á¦¡£×÷ΪÉñ¾­¿ÆѧµÄÏÈÐÐÕß £¬ÎÒÃÇÏàÐÅսʤÕâÖÖ¼²²¡ÐèÒª¶àÖÖÒªÁìºÍÖÎÁÆÑ¡Ôñ £¬ÎÒÃÇÆÚ´ýÓ뻼Õß¡¢Ò½Ñ§¿Æѧ½çÁ¬Ðø̽Ë÷¡£¡±

 

2022Äê7Ô £¬ÃÀ¹úʳƷҩƷ¼à¶½¹ÜÀí¾Ö£¨Food and Drug Administration, FDA£©ÊÜÀíÁËÀ´Àû¹ú¼Êw66¹Ù·½ÍøÕ¾ÂØ¿¨Ä¹ÔÚ¿ìËÙͨµÀÈ϶¨ÏµÄÉúÎïÖÆÆ·Ðí¿ÉÉêÇ루BLA£© £¬²¢ÊÚÓèÓÅÏÈÉó²éȨ¡£´¦·½Ò©Óû§Óöȷ¨°¸µÄÐж¯£¨PDUFA£©ÈÕÆÚ¶¨ÓÚ2023Äê1ÔÂ6ÈÕ¡£FDAÒÑͬÒâClarity ADµÄ½á¹û×÷ΪÑéÖ¤ÐÔÑо¿À´Ö§³ÖÂØ¿¨Ä¹µÄÁÙ´²»ñÒ档ΪÁ˾¡¿ìÈ·±£FDA¶ÔÂØ¿¨Ä¹µÄÅú×¼ £¬À´Àû¹ú¼Êw66¹Ù·½Íøվͨ¹ýFDAµÄ¼ÓËÙÅú׼;¾¶Ìá½»ÁËBLA £¬ÒÔ±ã¸Ã»ú¹¹¿ÉÒÔÌáÇ°Íê³É¶ÔÑéÖ¤ÐÔClarity ADÑо¿ÍâµÄÂØ¿¨Ä¹È«²¿Êý¾ÝµÄÉó²é¡£

 

2022Äê3Ô £¬À´Àû¹ú¼Êw66¹Ù·½ÍøÕ¾¿ªÊ¼ÔÚÊÂÇ°ÆÀ¹À×ÉѯϵͳÏÂÏòÈÕ±¾Ò©Æ·ºÍÒ½ÁÆÆ÷е¾Ö£¨PMDA£©Ìá½»³ýClarity ADÊý¾ÝÍâµÄÉêÇë £¬Ä¿µÄÊǾ¡Ôç»ñµÃÂØ¿¨Ä¹µÄÅú×¼ £¬ÒÔ±ãÔçÆÚAD»¼Õß¿ÉÄܻᾡ¿ì½ÓÊÜÖÎÁÆ¡£

 

ÂØ¿¨Ä¹µÄÈ«Çò¿ª·¢ºÍ¼à¹ÜÌá½»ÓÉÀ´Àû¹ú¼Êw66¹Ù·½ÍøÕ¾Ö÷µ¼ £¬¶ø²úÎïÔòÓÉÀ´Àû¹ú¼Êw66¹Ù·½ÍøÕ¾ºÍ²³½¡ÅäºÏÉÌÒµ»¯ºÍÍƹã £¬ÆäÖÐÀ´Àû¹ú¼Êw66¹Ù·½ÍøÕ¾ÓµÓÐ×îÖÕ¾ö²ßȨ¡£